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Abstract
Rationale Deleterious effects of psychological stress onmem-
ory are increasingly important. Overexpression of the AT1
angiotensin receptors in brain has been found to participate in
several negative effects of chronic stress including hyperten-
sion and a cognitive impairment.
Objective In this study, we searched for the protective effects
the AT1 angiotensin receptor blockade with candesartan
against the adverse effects of repeated stress on recall of
aversively and appetitively motivated behaviours in rats.
Methods Two groups of male Wistar rats were repeatedly
stressed by keeping them daily (2 h/21 days) in tight plastic
tubes. The subjects of the group 1 received candesartan
(0.1 mg/kg, orally) each day before the stressing procedure.
The rats of the group 2 received vehicle. Another two groups
of rats (3 and 4) receiving candesartan and vehicle, respec-
tively, were appropriately handled but not stressed. Next day,
after ending the repeated stress procedure, all rats were tested
in two cognitive paradigms: inhibitory avoidance (IA) and
object recognition (OR).
Results Stressed animals displayed decreased recall of the
IA behaviour (p<0.01) and decreased OR (p<0.05). These
effects were not seen in the animals stressed and concomi-
tantly treated with candesartan. The auxiliary tests designed
to control for the possible unspecific contribution of motor
(open field) and emotional (elevated “plus” maze) effects of
the experimental procedures to results of the cognitive tests
showed no such contribution.
Conclusion These data strongly suggest that the AT1 angio-
tensin receptor blockade effectively counteracts deleterious
effects of stress on recall of aversively and appetitively
motivated memories in rats.
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Introduction
Most of us experience stressful situations every day. These
situations, perceived as a threat to our physical (e.g. traffic
dangerous situation) or psychological (e.g. loss of job) integ-
rity, evoke immediate adaptive mechanisms including activa-
tion of the hypothalamus–pituitary–adrenal (HPA), sympatho-
adrenomedullary and sympatho-neural axes (de Quervain et
al. 2009; Kvetnansky et al. 2009; Wolf 2009) initiated by
signals from the limbic cortical areas such as medial prefrontal
and cingulate cortex to paraventricular hypothalamic nucleus
(PVN). The adaptive processes however become maladaptive
and harmful to the organism once stressful stimuli occur
repeatedly for a long time (weeks or months). Deleterious
effects of chronic stress eventually manifest themselves in
several pathologies such as gastric ulceration, hypertension,
depression and a cognitive impairment (Buchanan et al. 2006;
de Quervain et al. 1998; de Quervain et al. 2000; Saavedra
2005; Terfehr et al. 2011 ).
In the last few years, our laboratory has been particularly
interested in the latter negative effect of stress in respect of
its possible alleviation by simple and easy prevention by for
example plant medicines such as the extracts from ginkgo
biloba (Walesiuk et al. 2005, 2006) and St. John's wort
(Trofimiuk and Braszko 2008; Trofimiuk et al. 2011) or
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dietary additive such as cod liver oil (Trofimiuk and Braszko
2011). Although mildly effective, these medicines do, by no
means, sufficiently solve the problem of coping with stress-
induced memory impairments.
In this context, recent discoveries by Saavedra's labora-
tory summarised in an excellent review (Saavedra et al.
2011) that candesartan and other AT1 angiotensin receptor
blockers (ARBs) are extremely effective in the prevention or
at least alleviation of a wide range of the stress-induced
pathologies including gastric ulceration, adverse alterations
of cerebrovascular structure and function in spontaneously
hypertensive rats predisposing to brain ischemia and stroke
and also brain inflammation appeared very promising.
Importantly, part of the protective effects of ARBs was
found to be unrelated to the inhibition of the angiotensin
AT1 receptors and normalisation of blood pressure.
In rats, stress-induced overexpression of the AT1 angio-
tensin receptors in brain and periphery has been known for a
long time (Aguilera et al. 1995a, b; Castren and Saavedra
1988; Jezova et al. 1998; Leong et al. 2002; Yang et al.
1996). Various types of stress, through peripheral sympa-
thetic stimulation, increase renin activity and therefore pro-
duction of circulating angiotensin II (Ang II) (Xang et al.
1993). The peptide, by stimulating AT1 receptors, contrib-
utes to the secretion of ACTH from the pituitary gland and
subsequent release of mineralo- and glucocorticoids from
adrenal zona glomerulosa and catecholamines from adrenal
medulla (Ganong and Murakami 1987; Keller-Wood et al.
1986). Stress increases Ang II content in many brain regions
including the hypothlalamus (Xang et al. 1993). The result-
ing stimulation of the brain and pituitary Ang II systems,
together with the increased AT1 receptor expression, acti-
vates the HPA axis and enhances corticotrophin-releasing
hormone (CRH) formation and release (Aguilera et al.
1995a, b; Sumimoto et al. 1991) that further increases pitu-
itary ACTH release followed by an increase of corticoste-
rone formation and release (Ganong and Murakami 1987).
The corticosterone in rodents (and cortisol in most other
mammals) has been found to adversely affect retrieval of
memory (for review, see Woodson et al. 2003; de Quervain
et al. 2009).
In the present study, we attempted to counteract memory
impairment produced by prolonged restraint stress in rats by
simultaneously treating them with a low nonhypotensive dose
of an AT1 angiotensin receptor inhibitor candesartan. The ra-
tionale for this approach was based on the considerable in-
volvement of the Ang II AT1 receptor-mediated stimulation of
HPA axis in the stress response. To produce memory deficits,
we used daily 2-h restraint stress for 21 days (Magarinos et al.
1997; Walesiuk et al. 2005). Retrieval of memory of an
aversively, motivated behaviour was measured using an in-
hibitory avoidance (IA) test (Ader et al. 1972). For compari-
son, we also measured retrieval of memory of an object in the
object recognition (OR) test (Ennaceur and Meliani 1992)
wherein memorising is motivated positively by natural
curiosity.
To control for any unspecific contribution of the possible
stress and /or candesartan-induced changes in the animals'
motor performance to the results of our memory tests, we
tested locomotor exploratory activity of rats in separate
experimental and control groups. To control for the possible
bias of the results of our cognitive tests by fear/anxiety
resulted from the experimental procedure, we tested all rats
in the elevated “plus” maze (Pellow et al. 1985).
Methods and material
Subjects
The experiments were conducted on male Wistar Cri:WI
(Hannover) rats purchased from the Center for Experimental
Medicine, Bialystok, Poland. This strain of rats is bred under
special high standard nearly sterile conditions assuring their
specific pathogen-free health status regularly checked accord-
ing to the protocols provided by the Charles River
Laboratories. They were 2 months old, weighing 140–160 g
at the beginning of the study. The animals were then main-
tained in the temperature- (23 °C) and humidity- (50–60 %)
controlled animal room in groups of five under constant 12-h/
12-h light/dark cycle beginning at 0700 hours with free access
to standard laboratory food and tap water. Principles of labo-
ratory animal care according to the European Council
Directive of 24 November 1986 (6/609/EEC) were observed
in all procedures. All experiments were approved by the local
Ethics Commission for Animal Experimentation.
Procedures
Stress procedure and the drug treatment
Four groups or animals (n014–16) were used. Rats of the
groups 1 and 2 underwent repeated restraint stress procedure
described by Magarinos et al. (1997) with modifications
(Walesiuk et al. 2005). Briefly, each rat to be stressed was
daily placed in a restrainer (21 days/2 h) which was a tight
transparent plastic tube 20-cm long and 7 cm in diameter.
The restrainer was then closed with a Plexiglas lid. Both the
restrainer and the lid were perforated for breathing. The ani-
mals fit tightly in the restrainers, and it was not possible for
them to turn around. The subjects of group 1 received cande-
sartan (candesartan cilexetil, AstraZeneca Södertälje, Sweden,
0.1 mg/kg, orally) suspended in 0.5 % methylcellulose solu-
tion (vehicle) at the volume of 1 ml/kg. The animals of group
2 received vehicle of 1 ml/kg. Another two groups of rats (3
and 4) receiving candesartan and vehicle, respectively, were
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Retrieval of an aversively motivated behaviour was tested by
the IA paradigm (Ader et al. 1972). The test was conducted in
a one-trial learning, step-through situation, which utilises the
natural preference of rats for dark environment. After 2 min of
habituation to the dark compartment, the rat was placed on the
illuminated platform and allowed to enter into the dark com-
partment. Two more approach trials were given on the follow-
ing day with a 2-min interval. At the end of the second trial,
unavoidable scrambled electric footshock (0.25 mA, AC, 3 s)
was delivered through the grid floor of the dark compartment
(learning trial). The retrieval of IA was tested 24 h later by
placing the animal on the platform and measuring the latency
to re-enter into the dark compartment to a maximum of 300 s.
Object recognition
Memory of an appetitively (by curiosity) motivated behaviour
was studied in an OR test (Ennaceur and Meliani 1992). The
apparatus consisted of a plastic box 62-cm long, 38-cm wide
and 20-cm high covered with a wire mesh lid. The objects to
be discriminated were made of glass or porcelain and existed
in duplicate. They appeared to have no natural significance for
the rats, and they had never been associated with reinforce-
ment. They were heavy enough not to be displaced by the rats.
The procedure included two habituation sessions, with a 1-
h interval, whereby the rats were allowed for 3-min explora-
tion of the apparatus. Twenty-four hours later, the testing
began. The experimental session consisted of two trials, each
lasting 3 min. In the first trial (T1), the rats were exposed to
two identical objects A. In the second trial (T2), performed
60 min later, the rats were exposed to two objects, one of
which was a duplicate of the familiar object A (A′), in order to
avoid olfactory traits, and a new object B. From rat to rat, the
role (familiar or new object) as well as the relative position of
the two objects were counterbalanced and randomly permuted
during trial T2. These precautions were taken in order to
reduce object and place preference effects. The basic measure
was the time spent by the rat in exploring objects during trials
T1 and T2. Exploration of an object was defined as touching it
with the nose. Turning around or sitting on the object was not
considered an exploratory behaviour. The following variables
were defined: A, the time spent in exploring, objects A in T1;
A′ and B, the times spent in exploring respectively, the dupli-
cate of familiar and the new object in T2. Object recognition
was measured by the variable B−A′, and total exploration in
T2, by B+A′. Moreover, as B−A′ may be biassed by the
differences in the overall levels of exploration, the variable
B A0 Bþ A0= was also computed.
Open field
Locomotor exploratory activity was measured in an open field
which was a square white floor measuring 100×100 cm di-
vided by eight lines into 25 equal squares and surrounded by a
27-cm high wall as described earlier (Braszko et al. 1987)
Elevated plus maze
Anxiety was evaluated in an elevated plus maze (EPM) (con-
structed of grey-coloured wooden planks) consisting of two
open arms, 50 cm (length)×10 cm (width), and two enclosed
arms 50 cm (length)×10 cm (width)×40 cm (height), covered
by a removable lid, such that the open or closed arms were
opposite to each other. The maze was elevated to a height of
50 cm from the floor. The rat was placed for 5 min in a pretest
arena (60×60×35 cm, constructed of the same material) prior
to exposure to the maze. This step allows facilitation of ex-
ploratory behaviour. The experimental procedure was similar
to that originally described by Pellow et al. (1985) with some
modifications (Braszko 2004).
Experimental design
All behavioural experiments were performed the next day
after ending the repeated stress procedure. Each group of
animals underwent two kinds of tests provided that the
results of the second test were unlikely to be biassed by
the results of the first one. Accordingly, the rats tested for IA
behaviour (a 3-day test) after a 2-min habituation trial per-
formed at about 1000 hours on day 1 were then tested for
locomotor exploratory activity at 1400 hours on the same
day. The rats tested for OR in the morning were then tested
for anxiety in the EPM in the afternoon the same day at the
times as above.
Next day, after ending the experiments, the stressed rats
were randomly checked for gastric ulceration. Every fifth
animal was anaesthetized with the mixture of ketamine and
diazepam (60:4.5 mg/kg i.p.) and sacrificed. Its stomach
mucosa was then exposed, washed and examined visually
under the×5 magnification lens for gastric ulceration. In all
cases, the mucosa appeared pink with no visible signs of
injury of any kind.
Statistical analysis
The result of all the experiments were evaluated by ANOVA
I followed by Newman–Keuls test. Levels were deemed
significant at p<0.05.
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Results
Effects of the repeated stress and chronic candesartan
on retrieval of the inhibitory avoidance behaviour
ANOVA I of the times spent by all the rats on illumi-
nated platform of the apparatus yielded F(3,56)09.913,
p<0.0005, showing thus statistically significant group
differences (Fig. 1). Pairwise comparisons between the
groups made with Newman–Keuls test revealed the rats
treated with candesartan to have statistically significantly
(p<0.01) better retrieval of memory of the IA behaviour
than the control rats. The animals repeatedly stressed
showed opposite; they had statistically significantly (p<
0.05) worse retrieval of memory of the IA behaviour in
comparison to the control. The latter effect was abol-
ished in the stressed rats chronically treated with cande-
sartan. These animals had statistically significantly (p<
0.01) better retrieval of memory of IA than the stressed
but not candesartan-treated rats.
Effects of the repeated stress and chronic candesartan
on object recognition memory
The times spent in exploring objects A (variable A) was
comparable in all groups (Table 1). ANOVA I of the dis-
crimination rates (B−A′) in all rats yielded F(3,56)014.954,
p<0.0001, showing thus statistically significant differences
between the groups. Pairwise comparisons made with
Newman–Keuls test showed that the object recognition
memory (B−A′) was statistically significantly worse (p<
0.05) in the stressed group in comparison with the control
group and this effect was reversed by candesartan. The
stressed candesartan-treated animals had significantly (p<
0.05) better object recognition memory than the stressed but
not treated rats. In addition, not stressed candesartan-treated
animals also displayed statistically significantly (p<0.001)
better recognition memory than the control not stressed
and not candesartan treated-rats. There were no statisti-
cally significant effects of our treatments on the remain-
ing parameters measured in the OR test. Specifically, we
observed no changes in habituation (B+A′) and no bias of
the OR scores by the changes in the overall levels of
exploration B A0 Bþ A0=ð Þ
Effects of the repeated stress and chronic candesartan
on the locomotor exploratory activity in the open field
No statistically significant differences were found in the
numbers of crossing, rearings and bar approaches counted in
the open field in any of our experimental groups (Fig. 2).
ANOVA I of the counts of these behavioural parameters
yielded F(3,32)02.966, F(3,32)01.744 and F(3,32)02.994
(p>0.05 in all cases) showing no statistically significant dif-
ferences between the groups. This experiment demonstrates
no appreciable influence of unspecific motor effects of the
applied treatments on the results of our cognitive test.
Effect of the repeated stress and chronic candesartan
on the behaviour of rats in the elevated plus maze
ANOVA I of the times spent by individual rats in the open
arms of the elevated plus maze yielded F(3,32)00.857, p>
0.05, showing thus no significant differences between the
groups (Fig. 3). Also, ANOVA I of numbers of the open arm
entries made by individual rats yielded F(3,32)00.858, p>
0.05 pointing to absence of statistically significant differ-
ences between any of the four compared groups. Again, this
experiment allowed the conclusion that a nonspecific influ-
ence of fear/anxiety on the results of our cognitive tests was
unlikely.
Fig. 1 Effect of chronic candesartan (0.1 mg/kg/day, p.o., 21 days),
chronic restraint stress (2 h/21 days) or both in combination, on the
latency of the inhibitory avoidance. Bars represent means + SEM from
14–16 rats. ANOVA I and Newman–Keuls test: *p<0.05, vs control;
**p<0.01, vs control and stress groups; ***p<0.01, vs stress group
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Discussion
This study demonstrated that candesartan, a highly selective
AT1 Ang II receptor antagonist (Nishikawa et al. 1997), ef-
fectively prevented deleterious effects of the repeated stress on
retrieval of memory in rats. To clearly dissect out the effect of
candesartan on memory in both not stressed and repeatedly
stressed animals, we had to ensure lack of influence of our
stress procedure and candesartan on at least three factors: (1)
locomotor activity, (2) anxiety and (3) blood pressure. These
factors could obviously affect the animals' performance in our
cognitive tests (Braszko et al. 2003) that would unspecifically
bias their outcome. The results of the open field and the
elevated plus maze tests excluded the first two factors, and
the low nonhypotensive dose of candesartan (Nishikawa et al.
1997), purposefully used in this study, ensured lack of exces-
sive lowering of blood pressure in our rats.
Although several chronic stress procedures have been
shown to cause gastric ulceration (Salim 1988), the restraint
paradigm of 2 h daily/21 days employed in the present study
was harmless in this respect. An explanation might be in the
strain of Wistar rats used in our experiments that is considered
more resistant to stress-induced gastric ulceration in compari-
son to the other strains such as spontaneously hypertensive
rats, Wistar–Kyoto or Sprague–Dawley Rats used in similar
studies (Pare 1990). Altogether, in our model, a mild psycho-
social stress (McLaughlin et al. 2007) causing no typical
pathology such as gastric ulcers, decreased locomotion or
anxiety appeared to be used. This was a fortunate situation as
all these additional pathologies would make correct evaluation
of the results of our cognitive tests difficult or even impossible.
Interestingly however, a more severe, 6 h daily/21 days, stress
procedure was used by other authors to produce cognitive
deficits well correlated with hippocampal CA3 neuron dendrite
retraction (McLaughlin et al. 2007).
Although involvement of the renin–angiotensin system in
various stress-induced pathologies has been extensively studied
for almost two decades (for review, see Saavedra et al. 2011), to
our knowledge its participation in the impairment of memory
caused by stress has not been specifically addressed. In face of
the increasing number of stressful challenges brought by our
daily life, the importance of this issue cannot be overestimated.
Fortunately, a number of recently published data indicate, in
addition to the present results, that the popular drugs being AT1
Table 1 Effect of chronic candesartan (cand) and chronic stress on object recognition
Variables (s) Treatment
Control Stress Canda Stress + cand
A 31.87±1.76b 35.28±2.95 42.0±3.63 38.86±2.29
A′ 40.37±3.44 36.78±4.49 28.87±3.43 31.28±3.61
B 42.94±3.98 33.07±3.49 47.44±5.76 35.93±4.43
B−A′ 1.94±1.87 −6.14±1.80* 18.69±4.038** 4.64±2.03***
B+A′ 82.69±7.21 69.85±7.58 76.31±8.57 67.21±7.81
B A0 Bþ A0= 0.023±0.025 −0.1±0.036 0.24±0.087 0.069±0.047
a Rats were given candesartan (0.1 mg/kg/day, p.o., 21 days) and chronically stressed. For further details, see text
b Values (in seconds) are means (± SEM)
* p<0.05; ** p<0.001 (vs control and stress + candesartan); *** p<0.05 (vs stress and vs candesartan; ANOVA I and Newman–Keuls test; for further
details, see text)
Fig. 2 Effect of chronic
candesartan (0.1 mg/kg/day,
p.o., 21 days), chronic restraint
stress (2 h/21 days) or both in
combination, on the locomotor
exploratory activity of rats in
the open field. Bars represent
means + SEM from nine rats
Psychopharmacology (2013) 225:421–428 425
Ang II receptor inhibitors collectively called sartans (Saavedra
et al. 2011) may offer at least partial solution of the problem.
Sartans at present constitute the first-line treatment of hyper-
tension (Sestito 2011), a condition being a main risk factor for
myocardial infarction and stroke, the leading causes of overall
mortality. The sartans introduced to clinic in 1993 (Sneader
2005) and increasingly used ever since (Sestito 2011) proved to
be a safe and effective medication for hypertension and related
conditions such as left ventricular hypertrophy and diabetic
nephropathy (Chrysant 2008; Gansevoort et al. 1994; Ichihara
et al. 2001). Chronic stress is a well-known causative factor of
hypertension (Kvetnansky et al. 2009; Saavedra et al. 2011).
Therefore, in all cases of hypertension in which stress is impli-
cated as an aetiological factor, AT1 receptor blockade appears
to be much better treatment choice than the other drugs. The
mechanism of alleviation of hypertension-induced cognitive
deficits by angiotensin receptor type 1 blockers (the sartans)
most probably involves their ability to stimulate peroxisome
proliferator-activated receptor gamma (PPAR-γ) (Fournier et
al. 2009; Saxby et al. 2008; Schrader et al. 2007; Trenkwalder
2006). PPAR-γ agonism exerted mainly by telmisartan
(Haraguchi et al. 2010; Mogi et al. 2008; Tsukuda et al.
2009) but to a different extent also by all other sartans including
losartan, irbesartan and candesartan (Min et al. 2012; Schupp et
al. 2004) was found to be responsible for the memory improve-
ments after repeated cerebral ischemia in rats (Haraguchi et al.
2010) and β-amyloid injection (Tsukuda et al. 2009) or type 2
diabetes mellitus in mice (Min et al. 2012). Activation of the
PPAR-γ is also considered to participate in antidiabetic, anti-
inflammatory, and cholesterol profile-improving effects of sev-
eral drugs (Saavedra et al. 2011). In line with these consider-
ations is a recent clinical study demonstrating that sartans
improvememory and delay progression of Alzheimer's disease,
when compared to the other antihypertensive medications
(Li et al. 2010).
Importantly, the recall-alleviating effect of candesartan was,
in our present experiments, achieved at its very low dose
(0.1 mg/kg) only slightly affecting blood pressure in rats
(Nishikawa et al. 1997). Interestingly, candesartanwas effective
in protecting memory of both aversively motivated amygdala-
dependent IA behaviour (Ehrlich et al. 2009) and appetitively,
by curiosity, motivated medial prefrontal cortex-dependent
(Nelson et al. 2011) OR, bringing in both cases retrieval of
memory damaged by stress to normal. Again, memory of both
behaviours which was impaired by a 21-day chronic restraint
stressing procedure was fully preserved with low oral dose of
candesartan. For explanation of this preventive, against chronic
stress-induced cognitive impairment, action of candesartan
blockade to most if not all of the adverse effects of excessive
AT1 receptor signalling including overexpression of the AT1
receptors in PVN (Saavedra et al. 2006), decreased production
of CRH by parvocellular part of PVN and increased pituitary
ACTH content causing increased adrenal corticosterone pro-
duction (Armando et al. 2001, 2007; Baiardi et al. 2004)
leading, among other effects, to hippocampal atrophy
(Herbert et al. 2006; McLaughlin et al. 2007) appears most
probable. In addition, corticosterone (cortisol in humans) fur-
ther increases AT1 receptor expression in all parts of the HPA
axis creating thus a self-perpetuating mechanism (Saavedra et
al. 2004) leading to an allostatic overload (McEwen 2005;
McEwen and Stellar 1993), i.e. energy-consuming, exhausting
for an organism, new homeostasis (allostasis).
AT1 receptor blockade appears to break this sequence of
events at several levels including the brain cortex, hippocam-
pus, amygdala, hypothalamus, pituitary and adrenal glands
(Saavedra et al. 2011). Detailed mechanisms of translation of
this blockade to prevention of several stress-induced patholo-
gies including gastric ulceration, anxiety, posttraumatic stress
disorder, depression, hypertension and memory disturbances
are at present unknown and warrant further research.
Interestingly, candesartan clearly improved recall of the
IA behaviour not only in the stressed but also in not stressed
animals. Although explanation of this memory-enhancing
effect of the drug is difficult, alleviation of certain level of
the basal anxiety present in control rats may be considered.
Candesartan might then improve IA performance as the
result of emotional disinhibition. Such a normal cognition-
improving effect of another anti-stress medication with
Hypericum perforatum extracts was previously described
by Khalifa (2001) and in our recent study (Trofimiuk and
Braszko 2008).
Fig. 3 Effect of chronic candesartan (0.1 mg/kg/day, p.o., 21 days),
chronic restraint stress (2 h/21 days) or both in combination on the time
spent by rats in the open arms of the elevated “plus” maze and the
number of entries therein. Bars represent means + SEM from nine rats
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Anxiety-like behaviour in the plus maze was usually (Bondi
et al. 2008; Lapiz-Bluhm et al. 2008) but not always
(Cunningham et al. 2009) observed as a result of a chronic
restraint with additional unpredictable stressing stimuli, such as
an unscheduled lighting, wet bedding, unexpected noise, etc. in
Sprague–Dawley rats. Our 21-day/2-h daily stress procedure in
Wistar rats, conducted without the additional stress stimuli, has
never produced significant alterations in the parameters of
anxiety measured in the plus maze (Walesiuk et al. 2005;
Trofimiuk et al. 2005; Trofimiuk and Braszko 2011).
In conclusion, these results present experimental evi-
dence that the impairment of memory retrieval caused by
chronic restraint stress can be fully prevented by low con-
comitantly administered dose of candesartan. The drug is
already widely used as an antihypertensive (Khawaja and
Wilcox 2011) and clinical trials designed to test its, and
possibly other sartans, efficacy in stress-related memory
deficits should, in our opinion, be conducted.
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